Recall Initiation Date: 20220415: Report Date: 20220511: Classification Date: 20220503: Address: 666 Plainsboro Rd Bldg 200 Ste 230 Plainsboro, NJ 08536-0009 United States: Recalling Firm: Macleods Pharma Usa Inc: Initial Notification : Letter: Unique Ingredient Identifier: 0J48LPH2TH 3ST302B24A: Drug Application Number: ANDA202289; Structured Audience: Patient, Health Professional, Pharmacy.
The impacted products include: Accupril (Quinapril HCl Tablets), 10 mg Accupril (Quinapril HCl Tablets), 20 mg Accupril (Quinapril HCl Tablets), 40 mg
The recalled product lots were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from December 2019 to April 2022, according to the FDA notice.
Many of the drugs in the ARB class of blood pressure medications have been recalled, including: Candesartan Cilexetil Olmesartan Medoxomil Hydrochlorothiazide Amlodipine Besylate Telmisartan The drugs above only represent a portion of the affected pharmaceuticals.
Mark Lennihan/AP.
August 29, 2018 / 12:14 PM / CBS News.
about this recall, call Mylan 1-888-406-9305 May 2022 Class II Pantoprazole Sodium 01366809690 CGMP deviation If you have questions about this recall, Torrent Pharma Inc, 1-888-280-2040 May Hydrochlorothiazide 03334205007 03334205010 03334205044 03334205207 03334205210 03334205244 03334205107 03334205110 The recalled tablets were packaged in 90-count bottles and distributed to wholesalers and distributors across the U.S. and Puerto Rico from November 2019 to March 2022. So if youve purchased some blood pressure medications over the past few years, youve got lots to Drug manufacturer Pfizer has issued a nationwide recall of some blood pressure medication due to the presence of nitrosamine above Acceptable Daily Intake levels.
Pfizer Inc. is recalling a blood pressure drug because of elevated levels of a potential cancer-causing impurity.
Drug Recall DATE OF RECALL: October 12, 2021 DRUG NAME: Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets 04/30/2022 Irbesartan and Hydrochlorothiazide 300mg/12.5 mg tablets, 60 count* 68180-0414-06 H804192 H805348 H900065 H902264 08/31/2021 11/30/2021 12/31/2021
Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. Pfizer has recalled three blood pressure medications over concerns they are tainted with a possible carcinogen.
Hydrochlorothiazide is a type of medicine If you are not sure whether you should start taking this medicine, talk to your doctor. Tell your doctor if you have allergies to any other medicines When pregnancy is detected, lisinopril and hydrochlorothiazide should be discontinued as soon as possible.
Patients can also call 888-843-0247 8 a.m.-5 p.m.
Pfizer has issued a recall for a high blood pressure medication distributed under three names, according to the company. March 22, 2022.
Pfizer distributed Accuretic, the name-brand medication, and Greenstone, a subsidiary of Pfizer, distributed the generic tablets.
Please conduct a sub-recall to those accounts and communicate this recall information immediately.
The Accuretic recall was initiated after unsafe levels of a nitrosamine, N-nitroso-quinapril, were detected in the medications.
Promptly contact Sedgwick at 888-843-0247 (Mon.-Fri. 8 am-5 pm ET) to obtain e-paid pr (CNN) -- Pfizer has issued a recall for three high blood pressure medications, according to
Pfizer Voluntary Nationwide Recall of Lots of Accuretic (Quinapril HCl/Hydrochlorothiazide), Quinapril and Hydrochlorothiazide Tablets, and Quinapril HCl/Hydrochlorothiazide Tablets Due Recall - Due to N-NitrosoQuinapril Content Mar 23, 2022. If youre
When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus.
Below are the Theyre recalling all batches of their irbesartan tablets as well as Lisinopril.
Please request they immediately cease distribution quarantineand the affected product.
Pfizer has issued a recall for a Although neither amlodipine nor hydrochlorothiazide are currently under recall on their own, they are when combined with some other medications.
Pfizer suggests patients taking the tablets should consult with their health care provider or pharmacy to determine whether they've been given an affected batch. Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and hydrochlorothiazide and quinapril HCl/ hydrochlorothiazide) to the patient (consumer/user) level due to the presence of a nitrosamine, N
Background on the voluntary recall
ET Monday through Friday for instructions on how to return their product and get a refund.
On March 21, 2022 Pfizer announced a voluntary recall of several lots of its blood pressure medication Accuretic along with two generic versions of the drug - quinapril and hydrochlorothiazide and quinapril HCI/hydrochlorothiazide.
The recalled products were distributed from November 2019 to March 2022 throughout the United States and Puerto Rico.
Pfizer recalled another blood pressure medication on March 22. Product Recalls: March 16, 2022 April 13, 2022. Valsartan and Hydrochlorothiazide oral tablet, Lupin, 160 mg/12.5 mg, bottle, 90 count, NDC 68180-0104-09; Solco and Teva valsartan/hydrochlorothiazide tablets were affected by the recall. For more information, patients can contact Sedgewick at 888-843-0247 between 8 a.m. and 5 p.m. Pfizer has issued a recall for a high blood pressure medication distributed under three different names due to an increased risk of cancer, according to This time its Lupin Pharmaceuticals Inc. thats issued a voluntary recall. Company Announcement Accord Healthcare Inc. is voluntarily recalling One lot (Lot PW05264 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide Tablets USP, 12.5 mg, to the consumer level.
Sandoz recalled one lot of losartan and hydrochlorothiazide 100 mg/25 mg tablets in 1000 count bottles in November 2018 due to an impurity found in the active pharmaceutical ingredient. Taguig City, 04 March 2022 Sanofi, in agreement with the Philippine Food and Drug Administration, would like to inform you of the voluntary recall of several batches and a risk of market shortage for Irbesartan (Aprovel), Irbesartan + Amlodipine (Aprovasc ) and I rbesartan + Hydrochlorothiazide (CoAprovel).
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist.
A potentially life-threatening label mix-up has led to a nationwide recall of a high blood pressure medication, according to OverviewProvider RelationsCareLink Online ReferralsContinuing Medical EducationMayo Clinic LaboratoriesAskMayoExpertVideo CenterJournals and Publications Products Affected - Description. Recall of Accuretic (quinapril hydrochloride and hydrochlorothiazide) On 28 March 2022, all Accuretic (quinapril hydrochloride and hydrochlorothiazide) tablets were recalled at Pfizer voluntary nationwide recall of lots of ACCURETICTM (quinapril HCl/hydrochlorothiazide), quinapril and hydrochlorothiazide tablets, and quinapril HCl/hydrochlorothiazide tablets due to N-nitroso-quinapril content. By Madeline Holcombe, CNN. The recall, announced this week, concerns Accuretic tablets and two generics distributed by Greenstone: quinapril and hydrochlorothiazide, and quinapril HCI/hydrochlorothiazide. The FDA this week said that Lupin Pharmaceuticals is recalling batches of its Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets. Doctors use the medication to treat hypertension, low blood pressure, and symptoms in patients with type 2 diabetes.
Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and hydrochlorothiazide and quinapril HCl/ hydrochlorothiazide) to the patient (consumer/user)
Lupin Pharmaceuticals recalls 2 blood pressure medications Lupin Pharmaceuticals is voluntarily recalling certain dosages of All batches of
Hydrochlorothiazide capsules are indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Sandoz discontinued all losartan and
Some expiration dates extend into 2024. Pfizer is voluntarily recalling some antihypertensive medications because of unacceptable levels of a potential carcinogen, the
Recall Number: D-0895-2022: Event ID: 90200: Brand: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE: Generic Name: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE: Manufacturer: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE: Active Substance: HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM: Drug Route: ORAL: Valsartan and Hydrochlorothiazide Tablets. which may have received the recalled product.
0.
Specific lot numbers and photos of the drug bottles can be found in the recall announcement.
NEW YORK, NY., March 21,2022.
FOR IMMEDIATE RELEASE - NEW YORK, NY., March 21,2022. ET, Monday through Friday.
Distribution of all of these lots occurred from November 2019 through March 2022. Additional information can be found at https://www.fda.gov/Safety/Recalls/ucm625492.htm.
The recall, announced this week, concerns Accuretic tablets and two generics distributed by Greenstone: quinapril and hydrochlorothiazide, and quinapril HCI/hydrochlorothiazide. March 23, 2022 / 11:58 PM / CBS Boston. Unlike potassium sparing combination diuretic products, hydrochlorothiazide capsules may be used in those patients in whom the development of hyperkalemia cannot be risked, including patients taking ACE inhibitors.
(See Lisinopril, Fetal/Neonatal Morbidity and Mortality, below.) 5/21/2022.
Companies use these drugs to create variations of Losartan and Valsartan.
But, they are being recalled, so its a good idea to stop taking them and consult with your healthcare provider on another treatment.